IntelliPharmaCeutics International Inc (IPCIF)
0.10
0.00 (0.00%)
USD |
OTCM |
May 10, 16:00
IntelliPharmaCeutics International Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 30, 2019 | 6.575 |
| May 29, 2019 | 6.088 |
| May 28, 2019 | 5.940 |
| May 24, 2019 | 6.133 |
| May 23, 2019 | 6.550 |
| May 22, 2019 | 6.489 |
| May 21, 2019 | 6.692 |
| May 20, 2019 | 6.689 |
| May 17, 2019 | 6.307 |
| May 16, 2019 | 5.966 |
| May 15, 2019 | 6.134 |
| May 14, 2019 | 6.088 |
| May 13, 2019 | 5.820 |
| May 10, 2019 | 7.476 |
| May 09, 2019 | 4.919 |
| May 08, 2019 | 5.114 |
| May 07, 2019 | 4.890 |
| May 06, 2019 | 4.498 |
| May 03, 2019 | 4.434 |
| May 02, 2019 | 4.580 |
| May 01, 2019 | 4.891 |
| April 30, 2019 | 4.753 |
| April 29, 2019 | 5.114 |
| April 26, 2019 | 5.488 |
| April 25, 2019 | 5.800 |
| Date | Value |
|---|---|
| April 24, 2019 | 5.411 |
| April 23, 2019 | 5.313 |
| April 22, 2019 | 5.844 |
| April 18, 2019 | 6.304 |
| April 17, 2019 | 6.173 |
| April 16, 2019 | 6.380 |
| April 15, 2019 | 6.623 |
| April 12, 2019 | 7.220 |
| April 11, 2019 | 7.720 |
| April 10, 2019 | 7.050 |
| April 09, 2019 | 6.530 |
| April 08, 2019 | 5.562 |
| April 05, 2019 | 4.849 |
| April 04, 2019 | 5.222 |
| April 03, 2019 | 4.849 |
| April 02, 2019 | 5.042 |
| April 01, 2019 | 5.330 |
| March 29, 2019 | 5.442 |
| March 28, 2019 | 4.165 |
| March 27, 2019 | 4.312 |
| March 26, 2019 | 4.353 |
| March 25, 2019 | 4.238 |
| March 22, 2019 | 4.718 |
| March 21, 2019 | 4.307 |
| March 20, 2019 | 5.093 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
5.820
Minimum
May 13 2019
6.692
Maximum
May 21 2019
6.267
Average
6.134
Median
May 15 2019
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.4011 |
| Aurinia Pharmaceuticals Inc | 1.900 |
| Edesa Biotech Inc | 2.502 |
| Lexaria Bioscience Corp | 7.015 |
| Xenon Pharmaceuticals Inc | 3.297 |
Price to Book Value Related Metrics
| PS Ratio | 4.061 |
| Price to Free Cash Flow | 30.51 |
| Price | 0.10 |
| Earnings Yield | -92.00% |
| Market Cap | 3.309M |